A prespecified subgroup analysis of THEMIS trial investigated the association of ticagrelor to low-dose aspirin in patients with diabetes and previous PCI. The results, presented at ESC Congress 2019, showed a reduction of ischaemic events, suggesting a net clinical benefit with DAPT, as Philippe Gabriel Steg, Chief of cardiology at Hôpital Bichat AP-HP, Paris, commented at the press conference during ESC 2019.